HOME Press Releases Healthcare Analytics/Medical Analytics Market worth 29.84 Billion USD by 2022



Healthcare Analytics/Medical Analytics Market worth 29.84 Billion USD by 2022


The report "Healthcare Analytics/Medical Analytics Market by Type (predictive, prescriptive) Application (Clinical, RCM, Claim, Fraud, Waste, Supply Chain, PHM) Component (Service, Software) Delivery (On demand, Cloud) End User (Payer, Hospital, ACO) - Global Forecast to 2022", The healthcare analytics market is expected to reach USD 29.84 Billion by 2022 from USD 8.92 Billion in 2017, at a CAGR of 27.3%. The growth of the market is attributed to increasing government initiatives to increase EHR adoption, growing pressure to curb healthcare costs, availability of big data in healthcare, increasing venture capital investments, rising focus on improving patient outcomes, and technological advancements.

                              Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 336 Market Data Tables and 47 Figures spread through 362 Pages and in-depth TOC on "Healthcare Analytics/Medical Analytics Market by Type (predictive, prescriptive) Application (Clinical, RCM, Claim, Fraud, Waste, Supply Chain, PHM) Component (Service, Software) Delivery (On demand, Cloud) End User (Payer, Hospital, ACO) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/healthcare-data-analytics-market-905.html
Early buyers will receive 10% customization on reports.

The descriptive analytics segment is expected to dominate the market in 2017

Based on type, the healthcare analytics market is segmented descriptive, predictive, and prescriptive analytics. In 2017, the descriptive analytics segment is expected to account for the largest share of the healthcare analytics market. Descriptive analytics forms the base for the effective application of predictive or prescriptive analytics. Thus, descriptive analytics is expected to continue to dominate the healthcare analytics market during the forecast period.

The clinical analytics segment is projected to grow at the highest CAGR during the forecast period.

By applications, the healthcare analytics market is segmented into clinical analytics, financial analytics, operational and administrative analytics, and population health analytics. The clinical analytics segment is expected to grow at the highest rate during the forecast period. The high growth of this segment is attributed to the growing adoption of analytics by healthcare providers due to the rising pressure to curb healthcare costs, federal mandates such as the implementation of ICD-10 code sets, increasing adoption of electronic healthcare records, need to improve patient outcomes and reduce hospital readmission rates, and rising focus on personalized medicine-based analytics.

North America to dominate the healthcare analytics market

In 2017, North America is expected to dominate the market followed by Europe. The large share of the North American segment is attributed to factors such as the growing federal healthcare mandates to curb rising healthcare costs and provide quality care; increasing regulatory requirements; growing EHR adoption; and rising government initiatives focusing on personalized medicine, population health management, and value-based reimbursements.

The healthcare analytics market is highly competitive with the presence of several small and big players. Some of the players in the healthcare analytics market include Allscripts (US), Cerner (US), Health Catalyst (US), IBM (US), Inovalon (US), McKesson (US), MedeAnalytics (US), Optum (US), Oracle (US), SAS (US), Wipro (India), Verscend (US), CitusTech (US), VitreosHealth (US), and SCIO Health (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports